| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
NKT cells are true Ag-specific T cells that also have innate properties and form a bridge between the innate and adaptive immune systems. Distinct NKT cell subsets play positive and negative regulatory roles and define a new immunoregulatory axis with broad implications for tumor immunity and other immunological and disease settings.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. We apologize for not citing all works on the topic because of space limitations.
2 Address correspondence and reprint requests to Dr. Masaki Terabe or Dr. Jay A. Berzofsky, Vaccine Branch, National Cancer Institute, Building 10, Room 6B-12, Bethesda, MD 20892-1578. E-mail address: terabe{at}mail.nih.gov or berzofsk{at}helix.nih.gov
3 Abbreviations used in this paper: DC, dendritic cell; 
GalCer, -galactosylceramide; EAE, experimental autoimmune encephalitis; KO, knockout; Treg, T regulatory (cell).
This article has been cited by other articles:
|
|
 |
|
  H. Yuling, X. Ruijing, L. Li, J. Xiang, Z. Rui, W. Yujuan, Z. Lijun, D. Chunxian, T. Xinti, X. Wei, et al. EBV-Induced Human CD8+ NKT Cells Suppress Tumorigenesis by EBV-Associated Malignancies Cancer Res., October 15, 2009; 69(20): 7935 - 7944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Subleski and J. R. Ortaldo Editorial: NKT cells: to suppress or not to suppress, that is the question J. Leukoc. Biol., October 1, 2009; 86(4): 751 - 752. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Astrakhan, H. D. Ochs, and D. J. Rawlings Wiskott-Aldrich Syndrome Protein Is Required for Homeostasis and Function of Invariant NKT Cells J. Immunol., June 15, 2009; 182(12): 7370 - 7380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mortara, V. Frangione, P. Castellani, A. De Lerma Barbaro, and R. S. Accolla Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions Int. Immunol., June 1, 2009; 21(6): 655 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Terabe and J. A. Berzofsky NKT Cells and Cancer: Two Subsets Form a New Immunoregulatory Axis Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 203 - 208. [Full Text] [PDF]
|
|
|
|
|
|
M. Elkabets, Y. Krelin, S. Dotan, A. Cerwenka, A. Porgador, R. G. Lichtenstein, M. R. White, M. Zoller, Y. Iwakura, C. A. Dinarello, et al. Host-Derived Interleukin-1{alpha} Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells J. Immunol., April 15, 2009; 182(8): 4874 - 4881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Ko, J.-M. Lee, Y.-J. Kim, Y.-S. Kim, K.-A Lee, and C.-Y. Kang Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine J. Immunol., February 15, 2009; 182(4): 1818 - 1828. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
